Tüdőrák: vizsgálatok itt: Ausztrália
166 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePhase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Darlinghurst, Liverpool, Macquarie
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193 - 2/3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Where
- Heidelberg, Liverpool, Murdoch, Woodville South
- Életkor
- 18 év and over
- People
- 854 worldwide
- Run by
- AbbVie
See details and how to joinNCT07005102 - 2/3. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Where
- Fitzroy, Garran, Hobart, Kogarah, Nedlands, South Brisbane, St Albans
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- AbbVie
See details and how to joinNCT07155187 · EU 2025-521124-29-00 - 1/2. fázisTaking peopleML-016 in Advanced Cancer With Lung and/or Liver Involvement
- Where
- Buderim, Miranda, Wollongong
- Életkor
- 18 év and over
- People
- 108
- Run by
- BrYet US, Inc.
See details and how to joinNCT07723482 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Bedford Park, Camperdown, Clayton, Nedlands, South Brisbane
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Albury, Birtinya, Brisbane, Saint Leonards, Sydney
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 1. fázisTaking peopleOpen-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Where
- Melbourne, Randwick
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06625775 · EU 2024-519445-29-00 - 1. fázisTaking peopleTLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
- Where
- Camperdown, Malvern, Nedlands
- Életkor
- 18 év and over
- People
- 120
- Run by
- Treeline Biosciences, Inc.
See details and how to joinNCT07713732 - 3. fázisTaking peopleNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Where
- Heidelberg, Melbourne, Westmead
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00 - 3. fázisVisszavonvaA Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Where
- Hobart, Woolloongabba
- Életkor
- 18 év and over
- People
- 830 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00 - 1/2. fázisTaking peopleEvaluation of XYA02 in Patients With Advanced Solid Tumors
- Where
- Melbourne, Perth, Sydney
- Életkor
- 18 év and over
- People
- 190
- Run by
- XYone Therapeutics, Inc
See details and how to joinNCT07670312 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Camperdown, Melbourne
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 1. fázisTaking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Brisbane, Camperdown, Geelong, Sydney
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - 1. fázisVisszavonvaA Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
- Where
- Fitzroy, St Albans, Woolloongabba
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391670 · EU 2025-521639-34-00 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Where
- Liverpool, Melbourne, Subiaco, Woolloongabba
- Életkor
- 18 év and over
- People
- 416 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06618287 - 1/2. fázisTaking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Miranda, Saint Albans
- Életkor
- 18 év and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
- Where
- Adelaide, Campbelltown, Camperdown, Woolloongabba
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06855771 · EU 2024-519814-29-00 - 1/2. fázisNot yet taking people in AusztráliaStudy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Bedford Park, Blacktown, Heidelberg, Nedlands, Randwick, Sydney
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07435038 - 3. fázisTaking peoplePhase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Where
- Elizabeth Vale
- Életkor
- 18 év to 99 év
- People
- 400 worldwide
- Run by
- Amgen
See details and how to joinNCT07778316 - 1/2. fázisTaking peopleSL-28 for Advanced Solid Tumours
- Where
- Adelaide, Gold Coast, Sydney
- Életkor
- 18 év and over
- People
- 60
- Run by
- Second Life Therapeutics
See details and how to joinNCT07341737 - 1/2. fázisFut, nem toborozSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Adelaide, Clayton, Randwick, Southport
- Életkor
- 18 év and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185 - 1. fázisTaking peopleOpen-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Where
- Bedford Park, Darlinghurst, Frankston, Melbourne, Nedlands, Woodville South
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06343402 - 1. fázisTaking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Heidelberg, Perth, Southport, Waratah, Wollstonecraft
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - 1/2. fázisFut, nem toborozA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Melbourne, Randwick, South Brisbane, Sydney
- Életkor
- 18 év and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - 1/2. fázisTaking peopleStudy of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Where
- Clayton, Melbourne
- Életkor
- 18 év to 100 év
- People
- 280 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06726148 · EU 2024-517281-42-00